BLCM
BELLICUM PHARMS INCstockOTC
InactiveMar 4, 2024
0.07475USD-6.679%(-0.00535)6,059
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Richard Fair
HQ
Houston, Texas, USA
Feb 6, 2020 · 1-for-10 (reverse)
BLCM Profile
bellicum pharmaceuticals, located near the houston medical center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. we are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (hsct) and car t cell therapy. we are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.
BLCM Performance
| Period | Price | Date | Change |
|---|
